Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with dreadful clinical outcome. Tyrosine kinase inhibitors and immune checkpoint inhibitors are the only United States Food and Drug Administration-approved therapeutic options for patients with advanced HCC with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheu, Jacinth Wing-Sum, Lee, Derek, Li, Qidong, Goh, Chi Ching, Bao, Macus Hao-Ran, Yuen, Vincent Wai-Hin, Zhang, Misty Shuo, Yang, Chunxue, Chan, Cerise Yuen-Ki, Tse, Aki Pui-Wah, Sit, Grace Fu-Wan, Liu, Cindy Xinqi, Ng, Irene Oi-Lin, Wong, Chun-Ming, Wong, Carmen Chak-Lui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230009/
https://www.ncbi.nlm.nih.gov/pubmed/36893885
http://dx.doi.org/10.1016/j.jcmgh.2023.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230009/
https://www.ncbi.nlm.nih.gov/pubmed/36893885
http://dx.doi.org/10.1016/j.jcmgh.2023.03.001

Ejemplares similares